The World Health Organization identifies methamphetamine as the second most widely abused illicit drug after marijuana, and abuse of prescription amphetamines in the US is increasing. Drug addiction is a chronic and relapsing disorder, and relapse is thought to arise, in part, from the need to alleviate negative withdrawal symptoms such as anxiety and depression. Amphetamine abuse is associated with a withdrawal syndrome that includes increased anxiety states during drug abstinence. We have developed a rat model of heightened anxiety during amphetamine withdrawal and have identified changes in serotonergic neurotransmission within several key limbic brain areas that are important for fear, anxiety and stress states. The goal of the current proposal is to elucidate the mechanisms by which amphetamine withdrawal results in altered serotonergic neurotransmission, and directly relate these to heightened anxiety states and stress sensitivity during withdrawal. Furthermore this proposal will test traditional and novel pharmacotherapies in this rat model of amphetamine withdrawal, to determine whether normalizing serotonergic function in the brain reverses heightened anxiety states that are observed during abstinence from amphetamine.
Transition from amphetamine use to addiction may result, in part, from the need to alleviate dysphoric states, including heightened anxiety that emerge during drug abstinence. It is essential to understand the neurobiology underlying anxiety states during amphetamine withdrawal to identify potential pharmacotherapeutics, although very little research has been focused on this aspect of drug abuse. The current proposal will elucidate the neural mechanisms by which amphetamine withdrawal results heightened anxiety states and will test traditional and novel pharmacotherapies in a rat model of amphetamine withdrawal.
|Hemmings, Sian M J; Malan-Müller, Stefanie; van den Heuvel, Leigh L et al. (2017) The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study. Psychosom Med 79:936-946|
|Watt, Michael J; Weber, Matthew A; Davies, Shaydel R et al. (2017) Impact of juvenile chronic stress on adult cortico-accumbal function: Implications for cognition and addiction. Prog Neuropsychopharmacol Biol Psychiatry 79:136-154|
|Luo, Jialie; Feng, Jing; Yu, Guang et al. (2017) Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch. J Allergy Clin Immunol :|
|Solanki, Rajeshwari R; Scholl, Jamie L; Watt, Michael J et al. (2016) Amphetamine Withdrawal Differentially Increases the Expression of Organic Cation Transporter 3 and Serotonin Transporter in Limbic Brain Regions. J Exp Neurosci 10:93-100|
|Novick, Andrew M; Mears, Mackenzie; Forster, Gina L et al. (2016) Adolescent social defeat alters N-methyl-D-aspartic acid receptor expression and impairs fear learning in adulthood. Behav Brain Res 304:51-9|
|Lowry, Christopher A; Smith, David G; Siebler, Philip H et al. (2016) The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health. Curr Environ Health Rep 3:270-86|
|Bray, Brenna; Scholl, Jamie L; Tu, Wenyu et al. (2016) Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress. Brain Res 1644:278-87|
|Stamper, Christopher E; Hennessey, Patrick A; Hale, Matthew W et al. (2015) Role of the dorsomedial hypothalamus in glucocorticoid-mediated feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stress 18:76-87|
|Barr, J L; Rasmussen, B A; Tallarida, C S et al. (2015) Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat. Br J Pharmacol 172:5414-24|
|Rook, Graham A W; Lowry, Christopher A; Raison, Charles L (2015) Hygiene and other early childhood influences on the subsequent function of the immune system. Brain Res 1617:47-62|
Showing the most recent 10 out of 53 publications